Clinical trial reveals twice-yearly injection reduces risk of HIV infection by 96%
Powered by WPeMatico
Powered by WPeMatico
Powered by WPeMatico
Imphal: The Manipur police rescued a medical officer who was abducted from the Langthabal Kunja Awang Leikai area, with the kidnappers demanding a ransom. Five individuals, including a member of a banned outfit, have been arrested in connection with the abduction.
According to a PTI report, Dr Nabakeshore was abducted on November 22 from the Langthabal Kunja Awang Leikai area and the kidnappers later demanded a ransom, a police statement said.
“Acting swiftly, an operation by police led to the safe rescue of the victim from a farmhouse in Lamdeng under the Lamshang Police Station area on Sunday in Imphal West district,” it said.
Also Read:Odisha doctor goes missing from hospital quarter, Maoist hand suspected
Four individuals, including a member of the banned Kangleipak Communist Party, were arrested, the statement said.
Arms and ammunition were also recovered from their possession.
Another accomplice of the kidnappers was arrested on Tuesday, and arms and four detonators were seized from his possession, the police said, news agency PTI reported.
An investigation is underway to apprehend others accused in the case, the statement added.
Also Read:Thane Doctor kidnapped, released after Rs 30 lakh ransom; 5 arrested
Powered by WPeMatico
Ahmedabad: The Ahmedabad Municipal Corporation (AMC)-run SVP Hospital is under scrutiny following allegations of negligence after a patient’s death was reportedly linked to a non-functional CT scan machine.
The claims were brought to light by AMC corporator Jagdish Rathod from the Amraiwadi ward who expressed serious concerns about the hospital’s failure to provide timely care. Rathod has called for legal action against those responsible for the incident at SVP Hospital.
Also Read: Negligence in Ankle Surgery: Doctor, hospital ordered to pay Rs 3 lakh compensation
Rathod has formally requested the AMC health committee chairman to investigate the hospital’s alleged negligence, particularly focusing on the malfunctioning CT scan machine, which was out of order from November 23 to November 25.
As per a recent media report by TOI, Rathod, a Congress corporator, stated that the CT scan machine at SVP Hospital was not functional from Nov 23 to Nov 25. A family from Gomtipur, involved in an accident in Limdi, Surendranagar, brought seven severely injured members to the hospital.
However, due to the non-operational CT scan, essential diagnostic procedures were delayed, preventing the timely identification of critical injuries. Rathod also criticized the medical staff, mentioning that the orthopaedic and neurosurgeon failed to attend to the accident victims. One of the victims, Atul Chauhan, succumbed to his injuries after the delay in treatment. The allegations of delayed treatment, especially in emergency situations, have placed the hospital’s operations under intense scrutiny.
Also Read:Odisha: Allegedly delay in treatment, case filed against doctor and IGH Staff
The incident took place on April 21 when Neeraj rescued the severely injured person identified as Sheikh Basir, after a road accident near the Pantha Niwas region. He was reportedly asked to pay an amount of Rs 5000 in advance at IGH for the cost related to treatment.
Powered by WPeMatico
An Instagram reel claims that Fixing Gut Issues Cures Autism. The claim by the user is False.
An Instagram reel claims that Fixing The Gut Issues Cures Autism. In the reel by the_asd_mommy, the user writes “If you want to fix the brain of a child on the autism spectrum, fix the gut first.”
The reel is captioned, “Gut is the most important part of autism healing. If the gut is not fixed, the brain will also be in a mess. If your child is constipated or has diarrhea, fix it first and then see how things start improving.” It can be accessed here.
The claim by Instagram user is False. Fixing Gut Issues may help in managing the symptoms but it cannot Cure Autism. Autism is a neurodevelopmental condition and cannot be cured.
Autism, or autism spectrum disorder (ASD), encompasses a range of developmental conditions that affect brain function. Individuals with ASD experience varying challenges with social interactions, and communication and often display distinctive patterns in behaviors and activities. Common characteristics include difficulties transitioning between activities, intense focus on details, and unique sensory responses.
The needs and abilities of people with autism vary widely, with some capable of living independently while others may require lifelong support. Autism can significantly influence educational and employment opportunities, as well as place considerable demands on families and caregivers. Societal attitudes and the extent of support from both local and national entities often influence the quality of life for individuals with autism.
WHO says, “People with autism often have co-occurring conditions, including epilepsy, depression, anxiety and attention deficit hyperactivity disorder as well as challenging behaviors such as difficulty sleeping and self-injury. The level of intellectual functioning among autistic people varies widely, extending from profound impairment to superior levels.”
Autism is not a disease but a neurodevelopmental condition, meaning the brain develops differently from those without autism. Since it’s not an illness, there is no “cure” for autism. Instead, autism is a lifelong characteristic of how a person’s brain functions. While therapies and support can help individuals with autism manage specific challenges and improve quality of life, the condition itself is not something that can be treated or cured.
Gut issues also known as gut troubles, is a common experience, and can stem from various causes, ranging from simple indigestion to chronic conditions. While occasional pain may be due to dietary reactions or infections, persistent symptoms can indicate more serious digestive diseases.
Irritable bowel syndrome (IBS) is a group of symptoms that occur together, including repeated pain in your abdomen and changes in your bowel movements, which may be diarrhea, constipation, or both. With IBS, you have these symptoms without any visible signs of damage or disease in your digestive tract.
The prevalence of IBS in India is reported to range between 4.2% and 7.5%.
Fixing of gut issues depends on diagnosis and managmenet of the causes . Some of these gut issues can also be addressed with diet which also plays a major role in precention of gut issues. As per NHS, A diet for optimal gut health should include fiber-rich options like whole wheat, brown rice, fruits, and vegetables, along with adequate hydration for smoother digestion. Avoiding foods high in fat, fried items, caffeine, and aerated beverages can minimize gut discomfort. Incorporating lean proteins, low-fat dairy, and grilled dishes into a diet is beneficial, especially for those with digestive sensitivities. For individuals prone to gut issues, spicy, acidic, or allergenic foods such as chilies, tomatoes, citrus fruits, gluten, and dairy may need to be excluded. Prebiotics and probiotics are excellent additions for supporting a healthy gut environment.
Probiotics, often called “friendly bacteria,” are live microorganisms naturally present in the gut and found in foods like live yogurt or supplements. They help maintain gut health by balancing the gut microbiome and supporting digestion.
Prebiotics, on the other hand, are non-digestible fibers found in foods like garlic, onions, bananas, and asparagus, which nourish beneficial gut bacteria and enhance their growth. Together, probiotics and prebiotics work synergistically to improve gut health, support the immune system, and enhance nutrient absorption. For optimal benefits, probiotics should be consumed consistently for at least four weeks, while prebiotics can be included through a balanced diet.
Improving gut health may assist in managing certain autism-related symptoms. However, autism remains an incurable condition, and there is no scientific evidence to support the claim that fixing the gut issues cures autism.
Current research suggests that prebiotics and probiotics could offer targeted benefits for managing behavioral symptoms in autism spectrum disorder. A review article by Huan Yang et. al. suggests that preliminary evidence points to a beneficial preventive effect of probiotics and prebiotics on neurological and mental health conditions, including autism.
Similarly, findings from an article published in Frontiers in Psychology indicate that certain probiotics could play a role in improving various behavioral symptoms seen in autism.
A review by Pengya Feng et. al. highlights the promising potential of probiotics as a non-invasive therapy for managing autism symptoms by addressing gut microbiota dysbiosis and gut-brain axis dysfunction.
Gut-brain axis therapies may help manage autism-related symptoms. A study published in the Journal of Traditional and Complementary Medicine highlights that exploring the gut-brain axis may help manage autism-related neurological symptoms. It reviews therapies focused on the gut microbiome, showing promising results with interventions like probiotics, prebiotics, fecal microbiota transplantation (FMT), microbiota transfer therapy and dietary changes.
Research suggests that improving gut health may help ease certain symptoms associated with autism. However, autism is an incurable condition and cannot be completely cured. Hence, fixing gut issues cannot cure Autism.
Responding to the claim Dr Pallavi Gupta, Senior Resident, Department of Pediatrics, ESIC Hospital said “Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition with a variety of genetic, neurological, and environmental factors contributing to its development. While there is an observed link between gastrointestinal (GI) issues and autism, research suggests that addressing gut health can help improve certain symptoms, such as irritability, behavior, and quality of life for individuals with autism, but it does not cure the underlying condition. It is important to understand that Autism is a chronic condition and cannot be cured. Managing gut health can play a supportive role in the overall well-being of individuals with autism by potentially reducing discomfort and improving focus and behavior. However, it’s important for parents to seek comprehensive care from doctors, as treating gut issues isn’t a cure for autism.”
Dr Pretty Duggar Gupta, Consultant – Psychiatrist, Aster Whitefield Hospital, Bengaluru further said, “Fixing gut issues does not cure autism. Autism is a complex neurodevelopmental condition with multifactorial causes, and no single intervention can resolve it. However, research indicates that improving gut health and dietary habits may positively influence behaviors and overall well-being in individuals with autism. Addressing gut issues can help manage co-occurring symptoms, but it should be integrated into a holistic treatment plan that includes behavioral, educational, and medical interventions. Always seek advice from a qualified healthcare professional for a personalized approach.”
Enhancing gut health may aid in managing some symptoms associated with autism; however, autism remains an incurable condition with no available treatment. Currently, there is no scientific evidence or medical consensus to support the claim that Fixing The Gut Issues Can Cure Autism.
Hence, the claim by the Instagram user is False.
Powered by WPeMatico
Ahmedabad: Amid the scrutiny of Khyati Hospital, where two patients died following a botched angioplasty, disturbing revelations have come to light. Authorities have uncovered a series of serious malpractices that allegedly compromised patient safety and exploited government health schemes.
The investigation, led by the city crime branch, has raised serious concerns about the hospital’s practices. It has uncovered that the hospital was routinely conducting critical surgeries without anaesthetists and failing to provide adequate pre- or post-operative care, all in an apparent attempt to maximize profits.
As per the recent media report, a crime branch officer told TOI, “The hospital’s modus operandi was to conduct health check-up camps, identify beneficiaries of the Pradhan Mantri Jan Arogya Yojana (PM-JAY) and bring them to the hospital in Ahmedabad. Then, the patients were rushed into surgeries in ‘emergency mode’ — sometimes within hours of being admitted,” said an investigator. “Patients were also frequently discharged within 24 hours, which is unheard of for procedures like angioplasty,” the officer added.
The officer further stated that all medical records are under investigation, and post-dated or rough entries have been found, indicating the absence of an anaesthetist in the operation theatre during some of the procedures. It is believed that an employee at the hospital administered the anaesthesia, and this angle is being probed.
The hospital in its efforts to maximize profits has reportedly cut corners in its operations. Commenting on this an officer told TOI, “The hospital reused disposable medical items, skipped prescribed instruments, and operated without the required specialists in the room. We will question the accused individuals about this during the remand.”
Khyati Hospital’s profiteering strategy has reportedly exploited state and central government health schemes, particularly PM-JAY. Investigators revealed that nearly 70% of the hospital’s Rs.11 crore revenue over the past 18 months came from such schemes.
Also Read: PMJAY Beneficiaries Death Row: Khyati Hospital among 7 suspended from Ayushman Bharat
An investigator said that the remaining patients mainly came from smaller hospitals and general practitioners who allegedly received a cut from the amount the patient would spend at the hospital. He added that they were also scrutinizing the sarpanches of villages where the health camps were organized.
As authorities continue to probe further investigations are focused on how emergency procedures were sanctioned and funds disbursed under the PM-JAY scheme.
Powered by WPeMatico
Karnataka- Karnataka Examination Authority (KEA) has released the online stray vacancy round 2 seat allotment schedule for National Eligibility and Entrance Test-Undergraduate (NEET UG) AYUSH courses for the academic year 2024.
Unallotted AYUSH seats after the Stray Vacancy round seat allotment and the seats cancelled after the Stray Vacancy Round will be offered in the online second Stray Vacancy Round to the candidates who have not been allotted AYUSH seats through KEA. Therefore, interested candidates can participate in the second online stray vacancy round for the available AYUSH seats. Meanwhile, as per the schedule the newly registering candidates have to download the online verification slip from the KEA official website on after 29 November 2024, 3.00 pm and then enter the options.
SCHEDULE
S.NO |
PARTICULARS |
DATE & TIMINGS |
1 |
Display of seat matrix Seat matrix publication. |
29 November 2024-after 4.00 pm |
2 |
Entry of new options by eligible candidates. |
6.00 pm on 29 November 2024 to 02 December 2024 up to 12.00 Noon |
3 |
Publication of Stray Vacancy round-2 Provisional seat allotment results. |
02 December 2024 after 6.00 pm |
4 |
Publication of Stray Vacancy round-2 Final seat allotment results. |
03 December 2024 after 3.00 pm |
5 |
Payment of fees by seat allotted candidates. |
04 to 05 December 2024 |
6 |
Downloading of admission order after payment of admission order. |
|
7 |
Last Date for Reporting at the Allotted College along with originals and one set of attested photocopies as per verification slip. |
05 December 2024-before 5.30 pm |
Karnataka Examinations Authority is governed by the Governing Council headed by the Honourable Minister of Higher Education. The Government of Karnataka established the Common Entrance Test Cell in the year 1994 for conducting entrance tests and determining the eligibility/merit, for admission to the first year or first semester of full-time professional courses for Government share of seats in Medical, Dental, Indian systems of medicine and Homeopathy, B-Pharma, Pharma-D Courses.
To view the schedule, click the link below
Powered by WPeMatico
Japan: A recent observational cohort study published in the Journal of Diabetes Investigation has found a significant link between the deterioration of ankle reflexes and reduced kidney function in individuals with type 2 diabetes. This study highlights the potential of using simple neurological assessments, such as ankle reflex tests, as indicators of kidney health in diabetic patients, adding a new dimension to routine diabetic care.
“A reduction or absence of ankle reflexes is strongly and independently linked to a decline in estimated glomerular filtration rate (eGFR) in patients with type 2 diabetes,” the researchers reported.
Akifumi Kushiyama, Department of Pharmacotherapy, Meiji Pharmaceutical University, Kiyose City, Tokyo, Japan, and colleagues aimed to examine the association between the ankle reflex and the eGFR in patients with type 2 diabetes.
For this purpose, the researchers conducted a single-center, retrospective, observational cohort study, including 1,387 patients who underwent an ankle reflex examination between January 2005 and December 2015. The ankle reflex results were categorized into three groups: normal, decreased, and absent.
The primary outcome was a 40% reduction in eGFR from baseline. To assess the relationship between ankle reflex findings and eGFR loss, the researchers employed survival time analysis using the Kaplan–Meier method and regression analysis with a Cox proportional hazards model.
The findings of the study can be summarized as follows:
The current study identified a connection between ankle reflex abnormalities and eGFR decline in patients with type 2 diabetes. As the severity of ankle reflex impairment increased, the risk of eGFR decline also heightened. Moreover, even after adjusting for potential confounders such as other neurological symptoms, diabetes history, patient background, comorbidities, and medications, the deterioration of ankle reflexes remained independently associated with eGFR decline.
The study had several limitations. First, 1,699 patients were excluded due to the absence of an ankle reflex examination at their initial visit, with the decision to perform the test unclear. Second, the results could have been influenced by variations in the physician’s skill, though experienced specialists conducted the exams. Third, the researchers couldn’t distinguish between diabetic and non-diabetic nephropathy as causes for eGFR decline since kidney biopsies were not performed. Lastly, unknown confounders may have impacted results.
“Despite these limitations, the study found that deterioration of ankle reflexes was an independent risk factor for eGFR decline in type 2 diabetes,” the researchers concluded.
Reference:
Muramatsu, T., Yamamuro, D., Kushiyama, A., & Kikuchi, T. Deterioration in ankle reflex is associated with a reduced estimated glomerular filtration rate in patients with type 2 diabetes: A retrospective observational cohort study. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.14348
Powered by WPeMatico
Using a gene-screening method they created, Stanford Medicine researchers may have discovered why an effective chemotherapy damages heart cells-and they have identified a drug that could keep the heart cells beating.
The chemotherapy, doxorubicin, kills cancer cells, but it also causes heart cells to beat out of rhythm, organize incorrectly or die. If used in high doses or for extended periods, the drug can lead to heart failure, limiting its use despite its effectiveness in treating cancer.
“We’ve always wanted to find a way to stave off this toxicity,” said Joseph Wu, MD, PhD, a professor of cardiovascular medicine and the director of the Stanford Cardiovascular Institute.
Wu and Stanley Qi, PhD, an associate professor in bioengineering and a scholar at Sarafan ChEM-H, created a genetic screening tool that harnesses CRISPR, a gene-editing technology, to uncover genes that may be involved in doxorubicin-induced heart damage. The screen pinpointed a gene that seemed to be one of the key vehicles through which doxorubicin inflicted damage.
“This CRISPR screen is a valid tool for drug discovery,” said Wu, the Simon H. Stertzer, MD, Professor. “That, to me, is the key take-home message of the study.”
Wu and Qi share the senior authorship of the paper, published in Cell Stem Cell Nov. 7, describing the research. Chun Liu, PhD, an assistant professor at the Medical College of Wisconsin and a former Stanford Medicine postdoctoral researcher, and Mengcheng Shen, PhD, a researcher and instructor at the institute, are the lead authors on the paper.
The researchers knew that doxorubicin caused harm to heart cells, but they didn’t know which genes were involved in the damage. They narrowed their search to 2,300 genes that existing drugs already target.
“Most of the time, when you do a drug screen, you know what the target gene is, and then you screen for drugs that block that gene,” Qi said. But in this case, Wu and Qi didn’t know the target gene, so they used a new genetic screening technique to observe the effects of doxorubicin on heart cells that were derived from induced pluripotent stem cells, which can give rise to any cell in the body.
The researchers used CRISPR to turn on or turn off one of the 2,300 genes in the heart cells such that each cell had only one gene changed. They then doused those cells with doxorubicin and noted which ones survived. The question then was, Why did they survive? To find out, the researchers sequenced the DNA of each cell, looking for genetic markers.
They found that the healthiest cells after doxorubicin treatment lacked a gene called CA12, which catalyzes reactions involving carbon dioxide to maintain a variety of the body’s functions, such as respiration and the formation of saliva. The researchers did more genetic tests, deleting CA12 from heart cells and confirming their suspicion: Cells without CA12 resisted doxorubicin-induced toxicity. The details of what the gene does during doxorubicin treatment are not yet clear, Wu said, but he hopes to figure that out.
Once Wu and his team pegged CA12 as a genetic factor in doxorubicin toxicity, they wanted to find a way to stop the CA12 protein from damaging heart cells. They picked 40 drugs that inhibit carbonic anhydrase proteins such as CA12. They gave the drugs, along with doxorubicin, to groups of heart cells that were not genetically edited. They compared the groups’ survival rate to find which cells stayed healthiest throughout the treatment.
A drug called indisulam, currently being studied as a potential cancer treatment, helped cardiomyocytes survive doxorubicin toxicity. Indisulam protected the heart cells’ ability to relax and contract and aided in maintaining cellular processes.
The next step was to test indisulam in a living organism. They treated mice with doxorubicin, then fed one of two groups indisulam. The mice that had indisulam along with the doxorubicin fared better, with stronger heart function and fewer signs of heart atrophy. Their heart cells also maintained their structure better.
The researchers are interested in how indisulam stops CA12 activity and plan to do more tests on the drug candidate to curb doxorubicin’s toxicity. They also hope to study how multiple genes interact in heart cell damage rather than focusing on one gene’s effect at a time.
The researchers likewise have big goals for their newly developed CRISPR screen, hoping to apply the technology beyond heart cell toxicity. “It’s a proof of principle,” Wu said. “In the future you could use it for other types of toxicity or diseases. We think it’s a very powerful tool.”
Reference:
Chun Liu, Mengcheng Shen, Yanxia Liu, Amit Manhas, Shane Rui Zhao, Mao Zhang, Nadjet Belbachir, Lu Ren, Joe Z. Zhang, Arianne Caudal, Masataka Nishiga, Dilip Thomas, Angela Zhang, Huaxiao Yang, Yang Zhou, Mohamed Ameen, Nazish Sayed, June-Wha Rhee, Lei S. Qi, Joseph C. Wu, CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicity, Cell Stem Cell, 2024, https://doi.org/10.1016/j.stem.2024.10.007.
Powered by WPeMatico
Airway management plays a crucial role in anesthesiology, and anticipating and handling challenging intubations is essential for patient safety. Difficult airway situations are a major contributing factor to anesthesia-related fatalities, with the El-Ganzouri risk index (EGRI) being designed to predict difficult intubations by considering various clinical factors like mouth opening, thyromental distance, and Mallampati classification. Recent study evaluated the predictive efficacy of El-Ganzouri risk index (EGRI) scoring for difficult laryngoscopy and tracheal intubation using the King Vision™ video laryngoscope. Airway assessment was conducted pre-induction using EGRI score, and final laryngoscopy and intubation were performed using the King Vision™ video laryngoscope, with outcomes assessed using the Percentage of Glottic Opening (POGO), Fremantle scores, and the modified Intubation Difficulty Scale. A total of 250 patients were included, and the optimal cut-off value for EGRI score was found to be 3. The study found that EGRI scoring effectively predicted difficult laryngoscopy and tracheal intubation with the King Vision™ video laryngoscope, with sensitivity, specificity, and area under the curve (AUC) of 82%, 86%, and 0.9 for the POGO score and 74%, 92%, and 0.85 for the Fremantle score. The ease of tube placement, when assessed using a modified Intubation Difficulty Scale, had a sensitivity, specificity, and AUC of 95%, 86%, and 0.94, respectively.
Association of EGRI Scores and Difficult Tracheal Intubation
The EGRI score was determined preoperatively for each patient, with scores of 4 or higher indicating a high risk for difficult airway management. The study demonstrated a significant association between EGRI scores and various demographic and clinical parameters, as well as its utility in forecasting difficult tracheal intubation, particularly when measured by the Intubation Difficulty Scale. The findings indicated that EGRI scoring effectively predicted difficult laryngoscopy and tracheal intubation with the King Vision™ video laryngoscope, especially in comparison to other scoring systems. However, the study also identified a discrepancy between obtaining a good laryngoscopic view and achieving easy tracheal intubation, highlighting the need for standardized prediction systems for video laryngoscopes.
Strengths and Limitations of the Study
The study’s strengths included its prospective design, systematic use of multiple validated scoring systems, and the implication that EGRI effectively predicts difficult airways in patients intubated with King Vision™ VL. However, the study has some limitations including single-center nature, observational design, and absence of a control group using alternative video laryngoscopes, which should be considered in future research. Overall, the study concluded that EGRI scoring can effectively predict difficult laryngoscopy and tracheal intubation with the King Vision™ video laryngoscope, as demonstrated through the statistical analyses and comparison to other scoring systems.
Key Points
– The study aimed to evaluate the predictive efficacy of the El-Ganzouri risk index (EGRI) scoring for difficult laryngoscopy and tracheal intubation using the King Vision™ video laryngoscope. This involved conducting airway assessments pre-induction using EGRI scores and performing final laryngoscopy and intubation with outcomes assessed using the Percentage of Glottic Opening (POGO) score, Fremantle scores, and the modified Intubation Difficulty Scale.
– The study included 250 patients and found that the optimal cut-off value for the EGRI score was 3. The researchers determined that EGRI scoring effectively predicted difficult laryngoscopy and tracheal intubation with the King Vision™ video laryngoscope, with sensitivity, specificity, and area under the curve (AUC) of 82%, 86%, and 0.9 for the POGO score, 74%, 92%, and 0.85 for the Fremantle score, and 95%, 86%, and 0.94 for the modified Intubation Difficulty Scale.
– The association of EGRI scores and difficult tracheal intubation was assessed, with scores of 4 or higher indicating a high risk for difficult airway management. The findings indicated a significant association between EGRI scores and various demographic and clinical parameters, as well as its utility in forecasting difficult tracheal intubation, particularly when measured by the Intubation Difficulty Scale. – The study highlighted strengths such as its prospective design, systematic use of multiple validated scoring systems, and implications that EGRI effectively predicts difficult airways in patients intubated with the King Vision™ VL. However, it also noted limitations including the single-center nature, observational design, and absence of a control group using alternative video laryngoscopes, which should be considered in future research.
– Overall, the study concluded that EGRI scoring can effectively predict difficult laryngoscopy and tracheal intubation with the King Vision™ video laryngoscope, as demonstrated through statistical analyses and comparison to other scoring systems.
– The study emphasized the importance of standardized prediction systems for video laryngoscopes and highlighted the need for future research to address the identified limitations, including the single-center nature and absence of a control group using alternative video laryngoscopes.
Reference –
Baby AE, D’souza MC, Krishnakumar M, Kavalakkatt DD. Evaluating the predictive efficacy of the El‑Ganzouri risk index for difficult laryngoscopy and intubation with King Vision™ video laryngoscope: A prospective cohort study. Indian J Anaesth 2024;68:1003‑9
Powered by WPeMatico